J E Udelson

Summary

Affiliation: Rhode Island Hospital
Country: USA

Publications

  1. ncbi Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease
    J E Udelson
    Cardiac Imaging Core Laboratory, Division of Cardiology, New England Medical Center Hospitals Tufts University School of Medicine, Boston, MA 02111, USA
    Circulation 102:1605-10. 2000
  2. ncbi Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure
    J E Udelson
    Division of Cardiology, New England Medical Center Hospitals Tufts University School of Medicine, Boston, Massachusetts, USA
    Circulation 104:2417-23. 2001
  3. ncbi Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial
    James E Udelson
    Division of Clinical Care Research, Tufts New England Medical Center, 750 Washington St, Box 70, Boston, MA 02111, USA
    JAMA 288:2693-700. 2002
  4. ncbi Radionuclide imaging in heart failure: assessing etiology and outcomes and implications for management
    James E Udelson
    Division of Cardiology, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Mass 02111, USA
    J Nucl Cardiol 9:40S-52S. 2002
  5. ncbi Heart failure etiology affects peripheral vascular endothelial function after cardiac transplantation
    A R Patel
    Cardiovascular Imaging and Hemodynamic Laboratory, New England Medical Center Hospitals Inc, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    J Am Coll Cardiol 37:195-200. 2001
  6. ncbi Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunction
    J E Udelson
    Division of Cardiology, Department of Medicine, New England Medical Center, Boston, MA 02111, USA
    Am Heart J 139:503-10. 2000
  7. ncbi Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary
    M Simons
    Angiogenesis Research Center, BIDMC, Harvard Medical School, Boston, MA, USA
    Circulation 102:E73-86. 2000
  8. ncbi Bulls-eye display and quantitation of myocardial perfusion defects using three-dimensional contrast echocardiography
    J Yao
    Tufts NEMC, Box 32, 750 Washington St, Boston, MA 02111, USA
    Echocardiography 18:581-8. 2001
  9. ncbi Radionuclide imaging in risk assessment after acute coronary syndromes
    J E Udelson
    Division of Cardiology, Tufts-New England Medical Center Hospitals, Tufts University School of Medicine, Boston, Massachusetts, USA
    Heart 90:v16-25. 2004
  10. ncbi Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy
    M A Konstam
    Tufts University, New England Medical Center, Boston, MA 02111, USA
    Am Heart J 139:1081-7. 2000

Detail Information

Publications39

  1. ncbi Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease
    J E Udelson
    Cardiac Imaging Core Laboratory, Division of Cardiology, New England Medical Center Hospitals Tufts University School of Medicine, Boston, MA 02111, USA
    Circulation 102:1605-10. 2000
    ..We report the effects of the administration of recombinant fibroblast growth factor-2 (rFGF-2) protein on myocardial perfusion using single photon emission computed tomography imaging in humans with advanced coronary disease...
  2. ncbi Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure
    J E Udelson
    Division of Cardiology, New England Medical Center Hospitals Tufts University School of Medicine, Boston, Massachusetts, USA
    Circulation 104:2417-23. 2001
    ..Inhibiting the action of vasopressin may be beneficial in patients with heart failure...
  3. ncbi Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial
    James E Udelson
    Division of Clinical Care Research, Tufts New England Medical Center, 750 Washington St, Box 70, Boston, MA 02111, USA
    JAMA 288:2693-700. 2002
    ....
  4. ncbi Radionuclide imaging in heart failure: assessing etiology and outcomes and implications for management
    James E Udelson
    Division of Cardiology, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Mass 02111, USA
    J Nucl Cardiol 9:40S-52S. 2002
  5. ncbi Heart failure etiology affects peripheral vascular endothelial function after cardiac transplantation
    A R Patel
    Cardiovascular Imaging and Hemodynamic Laboratory, New England Medical Center Hospitals Inc, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    J Am Coll Cardiol 37:195-200. 2001
    ..These findings indicate that cardiac transplantation corrects peripheral endothelial function for patients without ischemic heart disease, but not in those with prior atherosclerotic coronary disease...
  6. ncbi Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunction
    J E Udelson
    Division of Cardiology, Department of Medicine, New England Medical Center, Boston, MA 02111, USA
    Am Heart J 139:503-10. 2000
    ....
  7. ncbi Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary
    M Simons
    Angiogenesis Research Center, BIDMC, Harvard Medical School, Boston, MA, USA
    Circulation 102:E73-86. 2000
    ....
  8. ncbi Bulls-eye display and quantitation of myocardial perfusion defects using three-dimensional contrast echocardiography
    J Yao
    Tufts NEMC, Box 32, 750 Washington St, Boston, MA 02111, USA
    Echocardiography 18:581-8. 2001
    ..1 +/- 2.4%). We conclude that bulls-eye display of contrast 3-D MCE demonstrates the site and extent of perfusion abnormalities in an easily appreciable manner. It also allows fast and accurate assessment of endangered myocardium...
  9. ncbi Radionuclide imaging in risk assessment after acute coronary syndromes
    J E Udelson
    Division of Cardiology, Tufts-New England Medical Center Hospitals, Tufts University School of Medicine, Boston, Massachusetts, USA
    Heart 90:v16-25. 2004
  10. ncbi Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy
    M A Konstam
    Tufts University, New England Medical Center, Boston, MA 02111, USA
    Am Heart J 139:1081-7. 2000
    ....
  11. ncbi Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease
    J T Kuvin
    Department of Medicine/Division of Cardiology, New England Medical Center Hospitals, Tufts University School of Medicine, Boston, Massachusetts, USA
    J Am Coll Cardiol 38:1843-9. 2001
    ..Further standardization of BAUS is required, however, before specific cut-points for excluding CAD can be established...
  12. ncbi American Society of Nuclear Cardiology position statement on radionuclide imaging in patients with suspected acute ischemic syndromes in the emergency department or chest pain center
    Frans J Th Wackers
    J Nucl Cardiol 9:246-50. 2002
  13. ncbi Acute resting myocardial perfusion imaging in patients with diabetes mellitus: results from the Emergency Room Assessment of Sestamibi for Evaluation of Chest Pain (ERASE Chest Pain) trial
    Athanasios Kapetanopoulos
    Hnry Low Heart Center for the Division of Cardiology, Hartford Hospital, Hartford, CT 06102, USA
    J Nucl Cardiol 11:570-7. 2004
    ..0002 for patients without DM and P = .35 for interaction of diabetes and RR reduction). CONCLUSIONS: Acute resting MPI with Tc-99m sestamibi is associated with improved triage decision making in symptomatic ED patients with diabetes...
  14. ncbi Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction
    Norman C Wang
    Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    JAMA 299:2656-66. 2008
    ..Hospitalization for heart failure is associated with high postdischarge mortality and morbidity. The predictive value of the QRS duration during admission for heart failure has not been well studied...
  15. ncbi MIBG imaging for selecting heart failure patients for defibrillator therapy: a first step
    Colin D Shafer
    J Nucl Cardiol 10:208-10. 2003
  16. ncbi Evaluation of a new ultrasound contrast agent (AI-700) using two-dimensional and three-dimensional imaging during acute ischemia
    Jiefen Yao
    Cardiovascular Imaging and Hemodynamic Laboratory Division of Cardiology, Department of Medicine, New England Medical Center, Tufts University School of Medicine, Boston, USA
    J Am Soc Echocardiogr 15:686-94. 2002
    ....
  17. ncbi Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials
    Mihai Gheorghiade
    Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Ill 60611, USA
    JAMA 297:1332-43. 2007
    ..Heart failure causes more than 1 million US hospitalizations yearly, mostly related to congestion. Tolvaptan, an oral, nonpeptide, selective vasopressin V2-receptor antagonist, shows promise in this condition...
  18. ncbi Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial
    Carey Kimmelstiel
    Division of Cardiology, Tufts-New England Medical Center, and Tufts University School of Medicine, Boston, Mass 02111, USA
    Circulation 110:1450-5. 2004
    ..Longer-term benefit likely requires more active chronic intervention, even among patients who appear clinically stable...
  19. ncbi Quantitative instruments for predicting risk ... and benefit
    James E Udelson
    J Am Coll Cardiol 45:730-2. 2005
  20. ncbi Screening the population for coronary artery disease: is it like screening for cancer?
    Prem Soman
    J Nucl Cardiol 12:145-7. 2005
  21. ncbi Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)
    Mihai Gheorghiade
    Division of Cardiology, Northwestern Feinberg School of Medicine, Chicago, IL, USA
    J Card Fail 11:260-9. 2005
    ..The results of EVEREST will determine whether these effects translate into improved clinical outcomes...
  22. ncbi Metabolic imaging with beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia
    Vasken Dilsizian
    Division of Nuclear Medicine, University of Maryland Hospital and School of Medicine, Baltimore, MD 21201 1595, USA
    Circulation 112:2169-74. 2005
    ..We hypothesized that a branched-chain fatty acid, beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid (BMIPP), might identify the presence of myocardial ischemia late after demand ischemia at rest up to 30 hours later...
  23. ncbi A head-to-head comparison of infusion and bolus doses of adenosine for stress myocardial contrast echocardiography
    Hans Joachim Nesser
    IInd Department of Medicine, Cardiology, KH der Elisabethinen Hospital, Linz, Austria
    Echocardiography 23:483-9. 2006
    ..This study was a head-to-head, intraindividual comparison of the diagnostic accuracy and side effect profile of bolus and infusion administration of adenosine for stress myocardial contrast echocardiography (MCE)...
  24. ncbi Assessment and key targets for therapy in the post-myocardial infarction patient with left ventricular dysfunction
    James D Flaherty
    Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA
    Am J Cardiol 102:5G-12G. 2008
    ..This review describes the current modalities for assessing the key pathophysiologic targets in post-MI patients with LVD and the effects of systemic factors on cardiac disease severity...
  25. ncbi Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial
    Marvin A Konstam
    Division of Cardiology, Tufts New England Medical Center, Boston, Mass, USA
    JAMA 297:1319-31. 2007
    ..Vasopressin mediates fluid retention in heart failure. Tolvaptan, a vasopressin V2 receptor blocker, shows promise for management of heart failure...
  26. ncbi Vascular endothelial dysfunction is associated with reversible myocardial perfusion defects in the absence of obstructive coronary artery disease
    Prem Soman
    Division of Cardiology, Tufts New England Medical Center, Boston, Mass, USA
    J Nucl Cardiol 13:756-60. 2006
    ..Recent evidence suggests that coronary endothelial dysfunction might play a role in the pathogenesis of these defects...
  27. ncbi The historical and conceptual evolution of radionuclide assessment of myocardial viability
    James E Udelson
    Division of Cardiology, Tufts-New England Medical Center, Boston, MA 02111, USA
    J Nucl Cardiol 11:318-34. 2004
  28. ncbi Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis
    Kevin C Allman
    Concord Hospital, Concord NSW, Australia
    J Am Coll Cardiol 39:1151-8. 2002
    ....
  29. ncbi Noninvasive assessment of left ventricular remodeling: concepts, techniques, and implications for clinical trials
    Inder S Anand
    Division of Cardiology, University of Minnesota Medical School and Veterans Administration Medical Center, Minneapolis, MN 55417, USA
    J Card Fail 8:S452-64. 2002
    ..CONCLUSIONS: Each of these techniques carries specific advantages and disadvantages for assessment of remodeling in individual patients and in the context of large-scale clinical trials...
  30. ncbi Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction
    James E Udelson
    Division of Cardiology, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, MA, USA
    J Card Fail 8:S465-71. 2002
    ....
  31. ncbi 34th Bethesda Conference: Executive summary--can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease?
    Allen J Taylor
    Cardiovascular Research, US Army Cardiology Service, Walter Reed Army Medical Center, WRAMC Building 2, Room 4A, 6900 Georgia Avenue NW, Washington, DC 20307, 5001
    J Am Coll Cardiol 41:1860-2. 2003
  32. ncbi Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy
    Barry J Maron
    The Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 E 28th St, Suite 60, Minneapolis, Minn 55407, USA
    Circulation 107:2872-5. 2003
  33. ncbi ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guideli
    Francis J Klocke
    Circulation 108:1404-18. 2003
  34. ncbi ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guideli
    Francis J Klocke
    J Am Coll Cardiol 42:1318-33. 2003
  35. ncbi New concepts in post-infarction ventricular remodeling
    James E Udelson
    Division of Cardiology, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA
    Rev Cardiovasc Med 4:S3-12. 2003
    ..It is also demonstrated that drug therapies that slow or reverse the remodeling process appear to have favorable natural history effects in the short term as well as during long-term therapy...
  36. ncbi Ventricular remodeling in heart failure: a credible surrogate endpoint
    Marvin A Konstam
    J Card Fail 9:350-3. 2003
  37. ncbi Role of beta-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunction
    Gregg C Fonarow
    Rev Cardiovasc Med 4:S54-9. 2003
  38. ncbi Ventricular remodeling in heart failure and the effect of beta-blockade
    James E Udelson
    Division of Cardiology, Tufts New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    Am J Cardiol 93:43B-8B. 2004
    ..Differences in their effect on remodeling have been recently shown among the beta-blockers. Several studies and a meta-analysis suggest that carvedilol may be more favorable to outcome, having the most effect on LV remodeling...
  39. ncbi Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy
    Martin S Maron
    Division of Cardiology, Hypertrophic Cardiomyopathy Center, Tufts Medical Center, Boston, Massachussetts 02111, USA
    Circulation 118:1541-9. 2008
    ..This study reports the prevalence, morphology, clinical course, and management of an underrecognized subgroup of HCM patients with left ventricular apical aneurysms...